Cingulate Inc (CING) Stock Price, Quote, News & History

CINGNASDAQ
$4.99
-0.13-2.54%
At close: Jun 18, 5:00 PM EST
$5.00
0.010.20%
After Hours: 7:42 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-19.55M
Investing Cash Flow (TTM)
-223.32K
Financing Cash Flow (TTM)
36.15M
Free Cash Flow (TTM)
-19.77M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
16.37M

Analyst Trends and Forecast

1
Mar
1
Apr
1
May
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$48.75M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
3.65
Earnings Yield % (TTM)
-84.74%
Earnings Yield % (FWD)
-50.68%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.40

Company Debt

Total Debt
$6.15M
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
$0
Total Cash
$25.89M
Debt to Equity
0.39
Issuance of Debt (TTM)
$6.00M
Repayment of Debt (TTM)
$0

Key Statistics

Open
$5.10
Close
$4.99
Volume / Avg.
506.50K / 630.83K
Day Range
$4.93 - $5.23
52 Wk Range
3.16 - 11.89
Market Cap
$67.35M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
20.95%
Days to Cover
3.06

About

Sector
Health Care
Industry
Pharmaceuticals
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an ini...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cingulate (CING) stock?

A

You can purchase shares of Cingulate (NASDAQ:CING) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cingulate (CING) competitors?

A

There are no as such competitors for Cingulate.

Q

What is the forecast, or price target, for Cingulate (CING) stock?

A

Cingulate has a consensus price target of $24.50.

Q

What is the current price for Cingulate (CING)?

A

The stock price for Cingulate (NASDAQ: CING) is $5 last updated June 18, 2026 at 7:42 PM EDT.

Q

Does Cingulate (CING) pay a dividend?

A

There are no upcoming dividends for Cingulate.

Q

When is Cingulate (NASDAQ:CING) reporting earnings?

A

Cingulate does not have any upcoming earnings scheduled.

Q

Is Cingulate (CING) going to split?

A

There is no upcoming split for Cingulate.

Q

What sector and industry does Cingulate (CING) operate in?

A

Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.